Last reviewed · How we verify
fospropofol sedation
At a glance
| Generic name | fospropofol sedation |
|---|---|
| Sponsor | Shanghai 6th People's Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Fospropofol Disodium ED95 for Elderly Spinal Anesthesia Sedation (PHASE4)
- Safety and Efficacy of Fospropofol vs Propofol During Invasive Mechanical Ventilation. (NA)
- Efficacy and Safety of Fospropofol for Same-day Bidirectional Endoscopy in Elderly Patients (PHASE4)
- Efficacy and Safety of Fospropofol Disodium Versus Propofol for Sedation in Mechanically Ventilated ICU Patients (PHASE2)
- Efficacy and Safety of Fospropofol Disodium Versus Propofol for Deep Sedation in Critically Ill Patients (PHASE2)
- A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective Colonoscopy (PHASE2)
- A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy (PHASE3)
- Fospropofol for Sedation During Elective Awake Intubation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- fospropofol sedation CI brief — competitive landscape report
- fospropofol sedation updates RSS · CI watch RSS
- Shanghai 6th People's Hospital portfolio CI